'This Isn't Normal, And It Isn't Pain-Free': Luke Rosen's Parenting Journey

Summary

The video is a CNBC Cures podcast episode hosted by Becky Quick, featuring Luke Rosen and Dr. Stan Crooke. It tells the story of Luke's daughter Susannah, who has an ultra-rare KIF1A neurodegenerative mutation, and the family's effort to found KIF1A.org and seek treatment through n-Lorem's antisense oligonucleotide program. The discussion covers the clinical effects of Susannah's ASO therapy, the science and history of antisense technology, and the emotional and family pressures of rare disease. It contains no explicit investment recommendations or actionable securities views.

• Becky Quick hosts a CNBC Cures episode about rare disease and KIF1A.
• Luke Rosen describes Susannah's diagnosis and the founding of KIF1A.org.
• Stan Crooke explains antisense technology, Ionis, and n-Lorem's nano-rare focus.
• Susannah's ASO treatment reportedly reduced tremor and neuropathy and improved energy and speech.
• The episode highlights family strain, nonprofit access, and limits of commercial drug development.
• No specific securities, tickers, or investment recommendations are presented.